Literature DB >> 18823926

Advanced treatment of the reverse osmosis concentrate produced during reclamation of municipal wastewater.

Emmanuel Dialynas1, Dionissios Mantzavinos, Evan Diamadopoulos.   

Abstract

The work investigated the treatment of the concentrate produced from the reverse osmosis treatment of an MBR effluent. Two conventional chemical processes, coagulation and activated carbon adsorption, and three advanced oxidation processes (electrochemical treatment, photocatalysis and sonolysis) were applied. Coagulation with alum gave dissolved organic carbon (DOC) removals up to 42%, while FeCl(3) achieved higher removals (52%) at lower molar doses. Adsorption with granular activated carbon showed the highest DOC removals up to 91.3% for 5 g/L. The adsorption isotherm was linear with a non-adsorbable organic fraction of around 1.2 mg/L DOC. The three oxidation methods employed, electrolytic oxidation over a boron-doped diamond electrode, UVA/TiO2 photocatalysis and sonolysis at 80 kHz, showed similar behavior: during the first few minutes of treatment there was a moderate removal of DOC followed by further oxidation at a very slow rate. Electrolytic oxidation was capable of removing up to 36% at 17.8A after 30 min of treatment, sonolysis removed up to 34% at 135W after 60 min, while photocatalysis was capable of removing up to 50% at 60 min.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823926     DOI: 10.1016/j.watres.2008.08.008

Source DB:  PubMed          Journal:  Water Res        ISSN: 0043-1354            Impact factor:   11.236


  2 in total

1.  Evaluation of the treatment of reverse osmosis concentrates from municipal wastewater reclamation by coagulation and granular activated carbon adsorption.

Authors:  Ying-Xue Sun; Zhe Yang; Tao Ye; Na Shi; Yuan Tian
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-31       Impact factor: 4.223

2.  The Analysis of a Microbial Community in the UV/O3-Anaerobic/Aerobic Integrated Process for Petrochemical Nanofiltration Concentrate (NFC) Treatment by 454-Pyrosequencing.

Authors:  Chao Wei; Wenjie He; Li Wei; Chunying Li; Jun Ma
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.